Advertisement

Topics

Companies Related to "Broccoli Unlikely Place Find Possible Anti Cancer Compound" [Most Relevant Company Matches] RSS

18:45 EDT 25th June 2019 | BioPortfolio

Here are the most relevant search results for "Broccoli Unlikely Place Find Possible Anti Cancer Compound" found in our extensive corporate database of over 50,000 company records.

Showing "Broccoli Unlikely Place Find Possible Anti Cancer Compound" Companies 1–25 of 4,100+

Relevant

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product candidate, Anti-EGFR‐TAP (SYN001) was derived from its platform technology termed A‐TAP (Antibody-Targeted Anti-Vascularization Payload). SYN001 is currently in preclinical ...


Chemonaut

Chemonaut provides online compound sourcing and procurement services to life science companies. The Chemonaut database is a comprehensive source of commercially available compounds for the most demanding researchers. The online application offers advanced search and filtering functionalities to construct a compound library tailored to your needs. Flexible import and export functions ensure that ...

Gibson Oncology, LLC

Gibson is a private oncology drug development company dedicated to bringing its novel, cost-effective, and very well-tolerated Indeno anti-cancer treatments to market. Gibson intends to develop these novel anti-cancer drugs in advanced-stage cancer patients as single agent and in combination treatments with both immunotherapy and targeted therapies.


Prolexys Pharmaceuticals, Inc.

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company’s therapeutic focus is on cancer and cardiovascular indications where Prolexys has identified novel, druggable therapeutic targets. Small molecules that act at these targets have been identified and tested in cell and animal models of diseas...

Biothera Pharmaceuticals Inc.

Biothera Pharmaceuticals is a privately held biotechnology company developing Imprime PGG, a first-in-class, mid-clinical stage cancer immunotherapy that orchestrates an integrated anti-cancer immune response in combination with checkpoint inhibitors and tumor-targeting and anti-angiogenesis monoclonal antibodies. Imprime PGG has been well-tolerated in tri...

Lpath

Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath's lead product candidate, Sphingomab™, is a monoclonal antibody (mAb) against a validated cancer target, sphingosine-1-phosphate (S1P), and has demonstrated compelling results against six different forms of sol...

Sopherion Therapeutics, LLC

Sopherion Therapeutics, LLC is a privately-held biotechnology company based in Princeton, New Jersey. The Company is focused on developing novel anti-cancer therapies for patients suffering from advanced cancer, particularly in the metastatic stage. Sopherion is dedicated to the acquisition, discovery, development and commercialization of novel anti-cancer therapies with unique therapeutic activi...

Goodwin Institute for Cancer Research

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a nonprofit cancer research facility dedicated to investigating and studying numerous types of cancer. Our goal is to find a cure or control for each cancer.

Pharmajobs.co.uk

Pharmajobs is the place to find your next job within the Pharmaceutical Industry. You will find vacancies for Field Based Professionals involved in the sales of Pharmaceuticals, Medical Equipment and Disposables. Opportunities range from Trainee Medical Representative up to Senior Management level. Pharmajobs creates a medium in which professionals seeking a new opportunity can find it, online via...

National Canine Cancer Foundation

The National Canine Cancer Foundation is a nationwide, contribution funded, 501 (c)(3) non-profit corporation dedicated to eliminating Cancer as a major health issue in dogs by funding grants directly to Cancer researchers who are working to save lives and find cures, better treatments and accurate, cost effective diagnostic methods in dealing with canine Cancer.

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit ...

Children’s Oncology Group

The Children’s Oncology Group (COG), a National Cancer Institute supported clinical trials group, is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. The COG unites more than 8,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across ...

Anti-Cancer Institute

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fully-human monoclonal antibody being developed for female malignancies. The OncoResponse discovery engine is working to increase the success rate of cancer immunotherapies by ident...

Ascenion

We advise public life-science research institutions in all aspects of intellectual property asset management. With our support, commercially attractive inventions, materials and know-how are promptly identified and given appropriate patent protection. We find suitable industrial partners, negotiate licensing and cooperation agreements, and accompany start-ups on the road to independence. Ideas the...

Inex Pharmaceuticals Corporation

INEX Pharmaceuticals Corporation is a biopharmaceutical company that utilizes proprietary drug delivery systems and therapeutic compounds to increase the effectiveness and reduce the side-effects of anti-cancer therapies. INEX's strategy has been to develop technology capable of making anti-cancer drugs more effective and reducing their side-effects, thus giving these drugs a competitive advantage...

Gadeta

Founded in 2015, Gadeta has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with an enhanced anti-cancer reactivity. Gadeta’s new cell-based anti-cancer product called T Cells Engineered To Express A Defined Gamma Delta TCR (TEGs) has strong therap...

St. Baldrick’s Foundation

The St. Baldrick’s Foundation makes grants to research institutions to find new cures for childhood cancer, and to find treatments to ensure a better quality of life for patients and survivors. The Foundation funds research projects conducted by established pediatric cancer experts, as well as young professionals who will be the experts of tomorrow. Fu...

The St. Baldrick’s Foundation

The St. Baldrick’s Foundation makes grants to research institutions to find new cures for childhood cancer, and to find treatments to ensure a better quality of life for patients and survivors. The Foundation funds research projects conducted by established pediatric cancer experts, as well as younger professionals who will be the experts of tomorrow. Funds ...

ANAVEX LIFE SCIENCES

Anavex Life Sciences Corp. ( www.anavex.com ) is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR(TM) Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances....

Orion Genomics.

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic patterns of DNA methylation, also known as DNA's Second Code.We are currently identifying epigenetic biomarkers and employing them in the development of novel molecular diagnostic tests to find breast...

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies.

ThromboGenics NV and BioInvent International

ThromboGenics is a biotechnology company focused on the discovery and development of innovative biopharmaceuticals for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additio...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focuses on making control or entrepreneur-driven investments. Since its formation in 1997, Irving Place Capital has been an investor in more than 50 companies and has raised over $4.0 ...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...


More From BioPortfolio on "Broccoli Unlikely Place Find Possible Anti Cancer Compound"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks